Researchers coupled a peptide that recognizes PD-L1 to an affinity peptide for tumour vasculature, which was subsequently added to methoxy poly(-ethylene glycol)3000-poly(ε-caprolactone)20000(MPEG-PCL) nanoparticles. This evidence concerns the gene CD274 and neoplasm.